Literature DB >> 25917101

Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens.

Dallas B Flies1, Tomoe Higuchi1, Lieping Chen2.   

Abstract

PD-1H is a recently identified cell surface coinhibitory molecule of the B7/CD28 immune modulatory gene family. We showed previously that single injection of a PD-1H agonistic mAb protected mice from graft-versus-host disease (GVHD). In this study, we report two distinct mechanisms operate in PD-1H-induced T cell tolerance. First, signaling via PD-1H coinhibitory receptor potently arrests alloreactive donor T cells from activation and expansion in the initiation phase. Second, donor regulatory T cells are subsequently expanded to maintain long-term tolerance and GVHD suppression. Our study reveals the crucial function of PD-1H as a coinhibitory receptor on alloreactive T cells and its function in the regulation of T cell tolerance. Therefore, PD-1H may be a target for the modulation of alloreactive T cells in GVHD and transplantation.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917101      PMCID: PMC4433880          DOI: 10.4049/jimmunol.1402648

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

Review 2.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 3.  Mechanisms maintaining peripheral tolerance.

Authors:  Daniel L Mueller
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

4.  Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.

Authors:  Vanessa M Hubbard; Jeffrey M Eng; Teresa Ramirez-Montagut; Kartono H Tjoe; Stephanie J Muriglan; Adam A Kochman; Theis H Terwey; Lucy M Willis; Rafaella Schiro; Glen Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

5.  The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.

Authors:  Ronjon Chakraverty; Megan Sykes
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 6.  Emerging drugs for acute graft-versus-host disease.

Authors:  Yasser Khaled; Pavan Reddy; Oleg Krijanovski
Journal:  Expert Opin Emerg Drugs       Date:  2009-06       Impact factor: 4.191

Review 7.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

Review 8.  Mechanisms of costimulation.

Authors:  Arlene H Sharpe
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 9.  Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

Authors:  Brian T Fife; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.

Authors:  Randall H Friedline; David S Brown; Hai Nguyen; Hardy Kornfeld; Jinhee Lee; Yi Zhang; Mark Appleby; Sandy D Der; Joonsoo Kang; Cynthia A Chambers
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

View more
  27 in total

1.  B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cells.

Authors:  Weiwei Yu; Ling Chen; Sizheng Guo; Liqun Luo; Lieping Chen
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

Review 2.  VISTA: Coming of age as a multi-lineage immune checkpoint.

Authors:  M A ElTanbouly; E Schaafsma; R J Noelle; J L Lines
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

3.  A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma.

Authors:  Huafeng Liu; Xin Li; Li Hu; Min Zhu; Bailin He; Liqun Luo; Lieping Chen
Journal:  Cell Mol Immunol       Date:  2017-05-08       Impact factor: 11.530

4.  VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.

Authors:  Aaron Prodeus; Aws Abdul-Wahid; Amanda Sparkes; Nicholas W Fischer; Marzena Cydzik; Nicholas Chiang; Mays Alwash; Alessandra Ferzoco; Nathalie Vacaresse; Michael Julius; Reginald M Gorczysnki; Jean Gariépy
Journal:  JCI Insight       Date:  2017-09-21

Review 5.  Immunoregulatory functions of VISTA.

Authors:  Elizabeth C Nowak; J Louise Lines; Frederick S Varn; Jie Deng; Aurelien Sarde; Rodwell Mabaera; Anna Kuta; Isabelle Le Mercier; Chao Cheng; Randolph J Noelle
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.

Authors:  Sabrina Ceeraz; Susan K Eszterhas; Petra A Sergent; David A Armstrong; Alix Ashare; Thomas Broughton; Li Wang; Dov Pechenick; Christopher M Burns; Randolph J Noelle; Matthew P Vincenti; Roy A Fava
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

Review 7.  T Cell Cosignaling Molecules in Transplantation.

Authors:  Mandy L Ford
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 8.  The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.

Authors:  Wenwen Xu; TạMinh Hiếu; Subramaniam Malarkannan; Li Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 9.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Authors:  Weiping Zou; Jedd D Wolchok; Lieping Chen
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

10.  Expression of the checkpoint receptors LAG-3, TIM-3 and VISTA in peripheral T cell lymphomas.

Authors:  Carlos A Murga-Zamalloa; Noah A Brown; Ryan A Wilcox
Journal:  J Clin Pathol       Date:  2019-10-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.